Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Murdock Hm"'
Autor:
Hill K, Raney C, Jackson K, Murdock HM, Dawson E, Hamilton R, DeLisser H, Mamtani M, Aysola J
Publikováno v:
Advances in Medical Education and Practice, Vol Volume 12, Pp 863-869 (2021)
Krystal Hill,1 Catherine Raney,2 Kelli Jackson,3 H Moses Murdock,4 Erika Dawson,5 Roy Hamilton,2 Horace DeLisser,2 Mira Mamtani,6 Jaya Aysola2 1Department of Internal Medicine, Baylor College of Medicine, Houston, TX, USA; 2Perelman School of Medicin
Externí odkaz:
https://doaj.org/article/95f7ced9d51f4febbeb77911e913b90e
Autor:
R. C. Lindsley, Eunice S. Wang, Christopher J. Gibson, Phani K. Davineni, Murdock Hm, Harrison Tsai, Annette S. Kim, Harris Mh, Nardi, Lukasz P. Gondek
KMT2A partial tandem duplication (KMT2A-PTD) at 11q23.3 is associated with adverse risk in AML and MDS, is a potential therapeutic target, and is an attractive marker of measurable residual disease. High initial KMT2A-PTD RNA levels have been linked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b71c399b2caa3cd4bb07d57d14343436
https://doi.org/10.1101/2021.11.01.21265781
https://doi.org/10.1101/2021.11.01.21265781
Autor:
Kah-Leong Lim, Monica Schenone, Jacqueline S. Garcia, Eunice S. Wang, Yingtian Xie, Henry W. Long, Eric S. Winer, Vivian J. Bardwell, R. C. Lindsley, Lukasz P. Gondek, Eva Johanna Schaefer, Marlise R. Luskin, Clifford A. Meyer, Richard Stone, Rahul S. Vedula, Annie Apffel, Martin Carroll, Emmalee R. Adelman, Murdock Hm, Steven A. Carr, Paloma Cejas, Iman Fares, Mario Figueroa, Huan Wang, Christopher J. Gibson, Gearhart
SummaryBCOR and its paralog BCORL1 encode subunits of the Polycomb repressive complex 1.1 (PRC1.1) and are recurrently mutated in myeloid malignancies. We show that leukemia-associated BCOR/BCORL1 mutations unlink the PRC1.1 RING-PCGF enzymatic core
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fecef0e63b276ce52721deb286ccafe
https://doi.org/10.1101/2021.03.08.433705
https://doi.org/10.1101/2021.03.08.433705
Autor:
Murdock Hm
Publikováno v:
Southern medical journal. 47(12)
Autor:
Murdock HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Ho VT; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Mar 20; Vol. 15, pp. 1359113. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Autor:
Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Murdock HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ansuinelli M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Brock J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cutler CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Gooptu M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Shapiro R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Bat-Erdene D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ryan J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Contreras ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fell G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bone Marrow Transplant Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2024 Feb 27; Vol. 8 (4), pp. 978-990.
Autor:
Aysola J; Penn Medicine Center for Health Equity Advancement, Office of the Chief Medical Officer, University of Pennsylvania Health System, Philadelphia, PA 19104, United States.; Office of Inclusion, Diversity, and Equity, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA 19104, United States.; Department of Medicine, Perelman School of Medicine, University of PA, Philadelphia, PA 19104, United States.; Department of Pediatrics, Perelman School of Medicine, University of PA, Philadelphia, PA 19104, United States., Murdock HM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States., Lett E; Penn Medicine Center for Health Equity Advancement, Office of the Chief Medical Officer, University of Pennsylvania Health System, Philadelphia, PA 19104, United States.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA 02115, United States., Williams C; MedStar Georgetown University Hospital, Washington, DC 20007, United States., Wade R Jr; Department of Pediatrics, Perelman School of Medicine, University of PA, Philadelphia, PA 19104, United States.; Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19178, United States., Higginbotham EJ; Office of Inclusion, Diversity, and Equity, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA 19104, United States.; Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.
Publikováno v:
Epidemiologic reviews [Epidemiol Rev] 2023 Dec 20; Vol. 45 (1), pp. 140-145.
Autor:
Rapaport F; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Clinical and Translational Science, The Rockefeller University, New York, NY, USA., Seier K; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Neelamraju Y; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Hassane D; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Baslan T; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gildea DT; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Haddox S; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Lee T; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Murdock HM; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Sheridan C; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Thurmond A; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Wang L; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Carroll M; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Cripe LD; Simon Cancer Center, Indiana University, Indianapolis, IN, USA., Fernandez H; Department of Malignant Hematology & Cellular Therapy, Moffitt Cancer Center, Tampa, FL, USA., Mason CE; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, USA., Paietta E; Montefiore Medical Center, Bronx, NY, USA., Roboz GJ; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, USA., Sun Z; Dana-Farber Cancer Institute, Boston, MA, USA., Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gönen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Levine R; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Melnick AM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Kleppe M; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Garrett-Bakelman FE; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA. fg5q@virginia.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. fg5q@virginia.edu.; Department of Medicine, University of Virginia, Charlottesville, VA, USA. fg5q@virginia.edu.; University of Virginia Cancer Center, Charlottesville, VA, USA. fg5q@virginia.edu.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Jul 06; Vol. 13 (1), pp. 103. Date of Electronic Publication: 2023 Jul 06.
Autor:
Murdock HM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ehrie J; Department of Psychiatry, Columbia University, New York, NY, USA., Bennett NL; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kogan JR; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Diagnosis (Berlin, Germany) [Diagnosis (Berl)] 2023 Apr 21; Vol. 10 (3), pp. 313-315. Date of Electronic Publication: 2023 Apr 21 (Print Publication: 2023).
Autor:
Rapaport F; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Clinical and Translational Science, The Rockefeller University, New York, NY, USA., Seier K; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Neelamraju Y; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Hassane D; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Baslan T; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gildea DT; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Haddox S; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Lee T; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Murdock HM; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Sheridan C; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Thurmond A; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA., Wang L; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Carroll M; Division of Hematology and Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Cripe LD; Simon Cancer Center, Indiana University, Indianapolis, IN, USA., Fernandez H; Department of Malignant Hematology & Cellular Therapy, Moffitt Cancer Center, Tampa, FL, USA., Mason CE; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.; The WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, USA., Paietta E; Montefiore Medical Center, Bronx, NY, USA., Roboz GJ; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, USA., Sun Z; Dana-Farber Cancer Institute, Boston, MA, USA., Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhang Y; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gönen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Levine R; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Melnick AM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Kleppe M; Human Oncology and Pathogenesis Program, Molecular Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Garrett-Bakelman FE; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA. fg5q@virginia.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. fg5q@virginia.edu.; Department of Medicine, University of Virginia, Charlottesville, VA, USA. fg5q@virginia.edu.; University of Virginia Cancer Center, Charlottesville, VA, USA. fg5q@virginia.edu.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2022 Sep 23; Vol. 12 (9), pp. 137. Date of Electronic Publication: 2022 Sep 23.